BiotechTube

efzofitimod 450 mg + efzofitimod 270 mg + Placebo

Phase 2Recruiting
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Interstitial Lung Disease

Conditions

Interstitial Lung Disease

Trial Timeline

Oct 26, 2023 → Apr 1, 2026

NCT ID
NCT05892614

About efzofitimod 450 mg + efzofitimod 270 mg + Placebo

efzofitimod 450 mg + efzofitimod 270 mg + Placebo is a phase 2 stage product being developed by aTyr Pharma for Interstitial Lung Disease. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05892614. Target conditions include Interstitial Lung Disease.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05892614Phase 2Recruiting

Competing Products

20 competing products in Interstitial Lung Disease

See all competitors
ProductCompanyStageHype Score
Ferumoxytol + GadobutrolLipella PharmaceuticalsPhase 1
25
LP-08 80mg + Normal saline + LP-08 20mgLipella PharmaceuticalsPhase 2
44
tacrolimusAstellas PharmaPre-clinical
23
ASP3652 + PlaceboAstellas PharmaPhase 2
52
Mirabegron + PlaceboAstellas PharmaPhase 3
77
TacrolimusAstellas PharmaPhase 2/3
65
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Placebo + JNJ-42160443Johnson & JohnsonPhase 2
52
Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mgJohnson & JohnsonApproved
85
BOTOX + Placebo for BOTOXAbbViePhase 2
52
NS-863 Low Dose + NS-863 High DoseNippon ShinyakuPhase 2
52
INS316 solution for inhalation + hypertonic saline 3% sodium chloride solutionMerckPhase 2
52
Abituzumab 1500 mg + Abituzumab 500 mg + PlaceboMerckPhase 2
52
MK-2225 + PlaceboMerckPhase 1
33
Certican® + Neoral + Myfortic + Simulect® + CorticosteroidsNovartisPhase 3
77
Pirfenidone + PlaceboRochePhase 2
52
PD 0299685 at 15mg BID + PD 0299685 at 30mg BID + placebo for PD 0299685PfizerPhase 2
51
Tanezumab + Tanezumab + Tanezumab + TanezumabPfizerPhase 2
51
ERB-041PfizerPre-clinical
22
PF-04383119 + PlaceboPfizerPhase 2
51

Other Products from aTyr Pharma

Efzofitimod 1 mg/kg + Efzofitimod 3 mg/kg + PlaceboPhase 2
44
ATYR1940Phase 1/2
33
ATYR1940Phase 1/2
33
Efzofitimod 1.0 mg/kg or Placebo + Efzofitimod 3.0 mg/kg or Placebo + Efzofitimod 5.0 mg/kg or PlaceboPhase 1/2
33
ATYR1940 + PlaceboPhase 1/2
33